1. Home
  2. LAC vs ZVRA Comparison

LAC vs ZVRA Comparison

Compare LAC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lithium Americas Corp.

LAC

Lithium Americas Corp.

N/A

Current Price

$1.67

Market Cap

686.2M

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$11.87

Market Cap

664.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAC
ZVRA
Founded
2023
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
686.2M
664.7M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
LAC
ZVRA
Price
$1.67
$11.87
Analyst Decision
Hold
Strong Buy
Analyst Count
12
9
Target Price
$5.07
★ $25.25
AVG Volume (30 Days)
★ 7.5M
875.2K
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 159.21
EPS
N/A
★ 1.03
Revenue
N/A
★ $106,470,000.00
Revenue This Year
N/A
$43.42
Revenue Next Year
N/A
$16.20
P/E Ratio
★ N/A
$11.58
Revenue Growth
N/A
★ 350.91
52 Week Low
$1.78
$8.01
52 Week High
$6.96
$15.04

Technical Indicators

Market Signals
Indicator
LAC
ZVRA
Relative Strength Index (RSI) 29.45 59.95
Support Level N/A $9.58
Resistance Level $2.22 $12.19
Average True Range (ATR) 0.13 0.55
MACD 0.00 0.24
Stochastic Oscillator 1.85 87.41

Price Performance

Historical Comparison
LAC
ZVRA

About LAC Lithium Americas Corp.

Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: